Based on previous studies, PARP inhibitors play crucial roles in enhancing immunogenic cell death, regulating the tumor microenvironment, reversing immunosuppression, synergizing with immunotherapy, and influencing DNA damage repair and immune responses. Here, PARP1 is linked to neoplasm.